|
1
|
Angus DC and van der Poll T: Severe sepsis
and septic shock. N Engl J Med. 369:840–851. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cohen J, Vincent JL, Adhikari NK, Machado
FR, Angus DC, Calandra T, Jaton K, Giulieri S, Delaloye J, Opal S,
et al: Sepsis: A roadmap for future research. Lancet Infect Dis.
15:581–614. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Delano MJ and Ward PA: Sepsis-induced
immune dysfunction: Can immune therapies reduce mortality? J Clin
Invest. 126:23–31. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Romero-Bermejo FJ, Ruiz-Bailen M,
Gil-Cebrian J and Huertos-Ranchal MJ: Sepsis-induced
cardiomyopathy. Curr Cardiol Rev. 7:163–183. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li F, Lang F, Zhang H, Xu L, Wang Y and
Hao E: Role of TFEB mediated autophagy, oxidative stress,
inflammation, and cell death in endotoxin induced myocardial
toxicity of young and aged mice. Oxid Med Cell Longev.
2016:53803192016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yasuda S and Lew WY: Lipopolysaccharide
depresses cardiac contractility and beta-adrenergic contractile
response by decreasing myofilament response to Ca2+ in
cardiac myocytes. Circ Res. 81:1011–1020. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Suliman HB, Welty-Wolf KE, Carraway M,
Tatro L and Piantadosi CA: Lipopolysaccharide induces oxidative
cardiac mitochondrial damage and biogenesis. Cardiovasc Res.
64:279–288. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cavaillon JM: Exotoxins and endotoxins:
Inducers of inflammatory cytokines. Toxicon. 149:45–53. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fallach R, Shainberg A, Avlas O, Fainblut
M, Chepurko Y, Porat E and Hochhauser E: Cardiomyocyte Toll-like
receptor 4 is involved in heart dysfunction following septic shock
or myocardial ischemia. J Mol Cell Cardiol. 48:1236–1244. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Latz E, Xiao TS and Stutz A: Activation
and regulation of the inflammasomes. Nat Rev Immunol. 13:397–411.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schroder K and Tschopp J: The
inflammasomes. Cell. 140:821–832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rathinam VA, Vanaja SK and Fitzgerald KA:
Regulation of inflammasome signaling. Nat Immunol. 13:333–342.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim EJ, Park SY, Baek SE, Jang MA, Lee WS,
Bae SS, Kim K and Kim CD: HMGB1 increases IL-1β production in
vascular smooth muscle cells via NLRP3 inflammasome. Front Physiol.
9:3132018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu H, Su Z, Wu J, Yang M, Penninger JM,
Martin CM, Kvietys PR and Rui T: The alarmin cytokine, high
mobility group box 1, is produced by viable cardiomyocytes and
mediates the lipopolysaccharide-induced myocardial dysfunction via
a TLR4/phosphatidylinositol 3-kinase gamma pathway. J Immunol.
184:1492–1498. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hwang JS, Kang ES, Ham SA, Yoo T, Lee H,
Paek KS, Park C, Kim JH, Lim DS and Seo HG: Activation of
peroxisome proliferator-activated receptor gamma by rosiglitazone
inhibits lipopolysaccharide-induced release of high mobility group
box 1. Mediators Inflamm. 2012:3528072012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Drosatos K, Khan RS, Trent CM, Jiang H,
Son NH, Blaner WS, Homma S, Schulze PC and Goldberg IJ: Peroxisome
proliferator-activated receptor-g activation prevents
sepsis-related cardiac dysfunction and mortality in mice. Circ
Heart Fail. 6:550–562. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Green TR, Bennett SR and Nelson VM:
Specificity and properties of propofol as an antioxidant free
radical scavenger. Toxicol Appl Pharmacol. 129:163–169. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Marik PE: Propofol: An immunomodulating
agent. Pharmacotherapy. 25:28S–33S. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vasileiou I, Xanthos T, Koudouna E, Perrea
D, Klonaris C, Katsargyris A and Papadimitriou L: Propofol: A
review of its non-anaesthetic effects. Eur J Pharmacol. 605:1–8.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hans P, Deby-Dupont G, Deby C, Pieron F,
Verbesselt R, Franssen C and Lamy M: Increase in antioxidant
capacity of plasma during propofol anesthesia. J Neurosurg
Anesthesiol. 9:234–236. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vanlersberghe C and Camu F: Propofol.
Handb Exp Pharmacol. 227–252. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang J, Hu JJ, Lu CH, Liang JN, Xiao JF,
Liu YT, Lin CS and Qin ZS: Propofol inhibits
lipopolysaccharide-induced tumor necrosis factor-alpha expression
and myocardial depression through decreasing the generation of
superoxide anion in cardiomyocytes. Oxid Med Cell Longev.
2014:1573762014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang Z, Cheng F, Yan G, Xiong L and Liu H:
Propofol protects against endotoxin-induced myocardial injury by
inhibiting NF-kB-mediated inflammation. Exp Ther Med. 15:2032–2036.
2018.PubMed/NCBI
|
|
24
|
Shinjo T, Tanaka T, Okuda H, Kawaguchi AT,
Oh-Hashi K, Terada Y, Isonishi A, Morita-Takemura S, Tatsumi K,
Kawaguchi M and Wanaka A: Propofol induces nuclear localization of
Nrf2 under conditions of oxidative stress in cardiac H9c2 cells.
PLoS One. 13:e01961912018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Javadov SA, Lim KH, Kerr PM, Suleiman MS,
Angelini GD and Halestrap AP: Protection of hearts from reperfusion
injury by propofol is associated with inhibition of the
mitochondrial permeability transition. Cardiovasc Res. 45:360–369.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jin YC, Kim W, Ha YM, Shin IW, Sohn JT,
Kim HJ, Seo HG, Lee JH and Chang KC: Propofol limits rat myocardial
ischemia and reperfusion injury with an associated reduction in
apoptotic cell death in vivo. Vascul Pharmacol. 50:71–77. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang B, You J, Qiao Y, Wu Z, Liu D, Yin
D, He H and He M: Tetramethylpyrazine attenuates
lipopolysaccharide-induced cardiomyocyte injury via improving
mitochondrial function mediated by 14-3-3g. Eur J Pharmacol.
832:67–74. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang H and Qu P: Effects of Ginkgo biloba
leaf extract on local renin-angiotensin system through TLR4/NF-κB
pathway in cardiac myocyte. Exp Ther Med. 14:5857–5862.
2017.PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Toldo S and Abbate A: The NLRP3
inflammasome in acute myocardial infarction. Nat Rev Cardiol.
15:203–214. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang Z, Zhuang X, Xie C, Hu X, Dong X,
Guo Y, Li S and Liao X: Exogenous hydrogen sulfide attenuates high
glucose-induced cardiotoxicity by inhibiting NLRP3 inflammasome
activation by suppressing TLR4/NF-κB pathway in H9c2 cells. Cell
Physiol Biochem. 40:1578–1590. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hsing CH, Chou W, Wang JJ, Chen HW and Yeh
CH: Propofol increases bone morphogenetic protein-7 and decreases
oxidative stress in sepsis-induced acute kidney injury. Nephrol
Dial Transplant. 26:1162–1172. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma X, Li SF, Qin ZS, Ye J, Zhao ZL, Fang
HH, Yao ZW, Gu MN and Hu YW: Propofol up-regulates expression of
ABCA1, ABCG1, and SR-B1 through the PPARγ/LXRα signaling pathway in
THP-1 macrophage-derived foam cells. Cardiovasc Pathol. 24:230–235.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Munford RS: Endotoxemia-menace, marker, or
mistake? J Leukoc Biol. 100:687–698. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Turdi S, Han X, Huff AF, Roe ND, Hu N, Gao
F and Ren J: Cardiac-specific overexpression of catalase attenuates
lipopolysaccharide-induced myocardial contractile dysfunction: Role
of autophagy. Free Radic Biol Med. 53:1327–1338. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu D, Yi B, Liao Z, Tang L, Yin D, Zeng
S, Yao J and He M: 14-3-3γ protein attenuates
lipopolysaccharide-induced cardiomyocytes injury through the Bcl-2
family/mitochondria pathway. Int Immunopharmacol. 21:509–515. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xianchu L, Lan PZ, Qiufang L, Yi L,
Xiangcheng R, Wenqi H and Yang D: Naringin protects against
lipopolysaccharide-induced cardiac injury in mice. Environ Toxicol
Pharmacol. 48:1–6. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Du J, An J, Wei N, Guan T, Pritchard KA Jr
and Shi Y: Increased resistance to LPS-induced myocardial
dysfunction in the brown norway rats versus Dahl S rats: Roles of
inflammatory cytokines and nuclear factor kappaB pathway. Shock.
33:332–336. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Matsuno K, Iwata K, Matsumoto M, Katsuyama
M, Cui W, Murata A, Nakamura H, Ibi M, Ikami K, Zhang J, et al:
NOX1/NADPH oxidase is involved in endotoxin-induced cardiomyocyte
apoptosis. Free Radic Biol Med. 53:1718–1728. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Essandoh K, Yang L, Wang X, Huang W, Qin
D, Hao J, Wang Y, Zingarelli B, Peng T and Fan GC: Blockade of
exosome generation with GW4869 dampens the sepsis-induced
inflammation and cardiac dysfunction. Biochim Biophys Acta.
1852:2362–2371. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu XR, Cao L, Li T, Chen LL, Yu YY, Huang
WJ, Liu L and Tan XQ: Propofol attenuates
H2O2-induced oxidative stress and apoptosis
via the mitochondria- and ER-medicated pathways in neonatal rat
cardiomyocytes. Apoptosis. 22:639–646. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Toldo S, Mezzaroma E, Mauro AG, Salloum F,
Van Tassell BW and Abbate A: The inflammasome in myocardial injury
and cardiac remodeling. Antioxid Redox Signal. 22:1146–1161. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Guo H, Callaway JB and Ting JP:
Inflammasomes: Mechanism of action, role in disease, and
therapeutics. Nat Med. 21:677–687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ulland TK, Ferguson PJ and Sutterwala FS:
Evasion of inflammasome activation by microbial pathogens. J Clin
Invest. 125:469–477. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Haneklaus M and O'Neill LA: NLRP3 at the
interface of metabolism and inflammation. Immunol Rev. 265:53–62.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Klune JR, Dhupar R, Cardinal J, Billiar TR
and Tsung A: HMGB1: Endogenous danger signaling. Mol Med.
14:476–484. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen HM, Liou SF, Hsu JH, Chen TJ, Cheng
TL, Chiu CC and Yeh JL: Baicalein inhibits HMGB1 release and
MMP-2/-9 expression in lipopolysaccharide-induced cardiac
hypertrophy. Am J Chin Med. 42:785–797. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ding HS and Yang J: High mobility group
box-1 and cardiovascular diseases. Saudi Med J. 31:486–489.
2010.PubMed/NCBI
|
|
49
|
Qin S, Wang H, Yuan R, Li H, Ochani M,
Ochani K, Rosas-Ballina M, Czura CJ, Huston JM, Miller E, et al:
Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med.
203:1637–1642. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang H, Ward MF and Sama AE: Novel
HMGB1-inhibiting therapeutic agents for experimental sepsis. Shock.
32:348–357. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ricote M and Glass CK: PPARs and molecular
mechanisms of transrepression. Biochim Biophys Acta. 1771:926–935.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhong CB, Chen X, Zhou XY and Wang XB: The
role of peroxisome proliferator-activated receptor g in mediating
cardioprotection against ischemia/reperfusion injury. J Cardiovasc
Pharmacol Ther. 23:46–56. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Takano H, Nagai T, Asakawa M, Toyozaki T,
Oka T, Komuro I, Saito T and Masuda Y: Peroxisome
proliferator-activated receptor activators inhibit
lipopolysaccharide-induced tumor necrosis factor-alpha expression
in neonatal rat cardiac myocytes. Circ Res. 87:596–602. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hong W, Hu S, Zou J, Xiao J, Zhang X, Fu
C, Feng X and Ye Z: Peroxisome proliferator-activated receptor
gamma prevents the production of NOD-like receptor family, pyrin
domain containing 3 inflammasome and interleukin 1β in HK-2 renal
tubular epithelial cells stimulated by monosodium urate crystals.
Mol Med Rep. 12:6221–6226. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Xu Y, Yao J, Zou C, Zhang H, Zhang S, Liu
J, Ma G, Jiang P and Zhang W: Asiatic acid protects against hepatic
ischemia/reperfusion injury by inactivation of Kupffer cells via
PPARγ/NLRP3 inflammasome signaling pathway. Oncotarget.
8:86339–86355. 2017. View Article : Google Scholar : PubMed/NCBI
|
